CN104173861A - Traditional Chinese medicine for treating prostatic cancer and preparation method thereof - Google Patents
Traditional Chinese medicine for treating prostatic cancer and preparation method thereof Download PDFInfo
- Publication number
- CN104173861A CN104173861A CN201410414774.9A CN201410414774A CN104173861A CN 104173861 A CN104173861 A CN 104173861A CN 201410414774 A CN201410414774 A CN 201410414774A CN 104173861 A CN104173861 A CN 104173861A
- Authority
- CN
- China
- Prior art keywords
- herba
- chinese medicine
- rhizoma
- preparation
- saururi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine for treating prostatic cancer and a preparation method thereof, and relates to a medicine for treating prostatic cancer. The traditional Chinese medicine is prepared from the following components in parts by weight: 60g of Chinese lobelia, 100g of dandelion, 15g of herba epimedii, 12g of stir-baked squama manitis, 100g of rhizoma smilacis glabrae, 60g of sculellaria barbata, 100g of herba violae, 19g of sweat cistanche, 30g of semen plantaginis, 15g of achyranthes root, 20g of fructus lycii, 10g of fried cortex phellodendri, 19g of honey-fried licorice root, 100g of saururus chinensis, 100g of lysimachia christinae hance, 25g of rhizoma sparganii and 30g of paniculate swallowwort root. The preparation method comprises the following steps: first, preparing each medicinal material according to the property of each medicinal material and a traditional Chinese medicine preparation method; and secondly, grinding the prepared medicinal materials into powder.
Description
Technical field: the present invention relates to a kind of medicine for the treatment of carcinoma of prostate, especially treat Chinese medicine and the preparation method of carcinoma of prostate.
Background technology: carcinoma of prostate is the malignant tumor that betides row body of gland, betides posterior lobe and the lateral lobe of body of prostate, especially with posterior lobe for the most common.Elderly men sickness rate is high, is more common in white people and black race, in U.S.'s carcinoma of prostate, accounts for 10% of male cancer, and its special onset rate is every 100,000 male 119.7, if the age is more than 75 years old, is 500/100000ths.Before clinical aobvious shape, split adenocarcinoma, the cancer of hiding is estimated as aobvious shape cancer 2-5 doubly, but before to split adenocarcinoma very rare at home, only account for the 0.19-0.28% of male cancer.
Modern medicine thinks that the cause of disease of primary disease it be unclear that, and it is generally acknowledged that in morbidity consubstantiality, androgen is relevant with the Balance disorders between estrogen.
How not obvious primary disease clinical manifestation early symptom is, often has albiduria frequency and nocturia in short-term.Along with the development of the state of an illness, can to occur urinating rheology thin, carrying out property dysuria, and urine Cheng Yanchang, dysurea and urine retention etc. has the symptom similar to row gland hypertrophy disease.Late period is visible hematuria and pain.Pain often shows as sacrum pain and lumbago and backache, and also visible sciatica, or pain is to perineum and the radiation of rectum portion.Advanced prostate cancer can be sent out along lymphatic channel and Blood route metastasis, invades and bone.Common metastasis site is common with pelvis, lumbar vertebra, femur and rib, and visceral metastases is in the majority with lung, is secondly the organs such as liver, pleura, kidney and brain.
The diagnosis of primary disease mainly relies on clinical manifestation and anus to refer to inspection.All in body of prostate any position touch the region that hardness increases, and have solid edge person, may have cancer to exist, but minority carcinoma of prostate is also being dispersed in property tuberosity, that touches is softer.Anus touch in late period can be touched to obtain enlargement, hard and nodositas focus.When pathological changes is invaded and seminal vesicle, can touch to obtain hard strand and the lump that stretches to side seam basin.Phosphatase acid serum is measured over 10K.A unit representation the concurrent transfer of carcinoma of prostate.Urine, prostatic fluid cytolgical examination finds the cancerous cell can assisted diagnosis, prostate biological tissue puncture or can make a definite diagnosis except pathological examination.X-ray is taken the photograph sheet, the diagnosis that isotope bone scanning contributes to bone to shift.
Modern medicine be take excision and radiotherapy as main to the treatment of primary disease.Operative treatment carcinoma is confined to the suitable row Prostate Cancer after Radical of person in prostate; Radiotherapy has the effect of necessarily appeasing to advanced carcinoma; The feasible male castration of endocrine therapy and use diethylstilbestrol.Apply in recent years cold therapy, also have certain curative effect.
Primary disease belongs to Chinese medicine " stranguria with blood ", categories such as " strangurias caused by overstrain " and " grand closing ".Motherland's medical science thinks that primary disease is how empty by deficiency of the kidney, stagnation of QI stasis blocking, damp and hot accumulateing due to strongly fragrant making a bet.
Summary of the invention: the object of this invention is to provide a kind of Chinese medicine and preparation method with the treatment carcinoma of prostate of good efficacy, it has made up the vacancy of China's treatment carcinoma of prostate to a certain extent, the object of the present invention is achieved like this, it is by Herba Lobeliae Chinensis 60g, Herba Taraxaci 100 g, Herba Epimedii 15 g, stir-baked SQUAMA MANITIS 12 g, Rhizoma Smilacis Glabrae 100 g, Herba Scutellariae Barbatae 60 g, Herba Violae 100 g, Herba Cistanches 19 g, Semen Plantaginis 30 g, Radix Achyranthis Bidentatae 15 g, Fructus Lycii 20 g, Cortex Phellodendri (parched) 10 g, Radix Glycyrrhizae Preparata 19 g, Rhizoma Saururi (Herba Saururi) 100 g, Herba Lysimachiae 100 g, Rhizoma Sparganii 25 g, Radix Cynanchi Paniculati 30 g make, its preparation method is: the first step, according to the characteristic of every sample medicine, is concocted respectively according to the concocting method of Chinese medicine, second step is pulverized, and the medicine cooking is ground into powdery.
The diuresis of Herba Taraxaci heat-clearing and toxic substances removing; Herba Scutellariae Barbatae heat-clearing and toxic substances removing dispersing tumor; The detumescence of Semen Plantaginis diuresis toxin expelling.
Treatment method: patient takes medicine 3 every day, each 6-10; Within 30 minutes after meal, take medicine, boiled water is taken after mixing it with water; 20 days courses for the treatment of, can control 3 courses for the treatment of, and take a turn for the better gradually.
Taboo: period in a medicine, taboo Fructus Capsici, Bulbus Allii; Old people can not eat egg, Ovum Anas domestica.
Therapeutic outcome, in decades to sick medication, the unwanted various virus of patient's whole body is all discharged, and in health, scarce thing is filled.Accept altogether 560 people for medical treatment, effective percentage 90%.
The specific embodiment: embodiment 1, the present invention are made by Herba Lobeliae Chinensis 30-90g, Herba Taraxaci 50-150g, Herba Epimedii 5-25g, stir-baked SQUAMA MANITIS 6-18g, Rhizoma Smilacis Glabrae 50-150g, Herba Scutellariae Barbatae 30-90g, Herba Violae 50-150g, Herba Cistanches 9-29g, Semen Plantaginis 20-40g, Radix Achyranthis Bidentatae 5-25g, Fructus Lycii 10-30g, Cortex Phellodendri (parched) 5-15g, Radix Glycyrrhizae Preparata 9-29g, Rhizoma Saururi (Herba Saururi) 50-150g, Herba Lysimachiae 50-150g, Rhizoma Sparganii 15-3525g, Radix Cynanchi Paniculati 20-40g, its preparation method is: the first step, according to the characteristic of every sample medicine, is concocted respectively according to the concocting method of Chinese medicine; Second step is pulverized, and the medicine cooking is ground into powdery.
Embodiment 2, the present invention are made by Herba Lobeliae Chinensis 50-70g, Herba Taraxaci 80-120g, Herba Epimedii 10-20g, stir-baked SQUAMA MANITIS 9-15g, Rhizoma Smilacis Glabrae 80-120g, Herba Scutellariae Barbatae 50-70g, Herba Violae 80-120g, Herba Cistanches 14-24g, Semen Plantaginis 20-40g, Radix Achyranthis Bidentatae 10-20g, Fructus Lycii 10-30g, Cortex Phellodendri (parched) 5-15g, Radix Glycyrrhizae Preparata 14-24g, Rhizoma Saururi (Herba Saururi) 80-120g, Herba Lysimachiae 80-120g, Rhizoma Sparganii 20-30g, Radix Cynanchi Paniculati 20-40g.
Embodiment 3, the present invention are made by Herba Lobeliae Chinensis 60g, Herba Taraxaci 100g, Herba Epimedii 15g, stir-baked SQUAMA MANITIS 12g, Rhizoma Smilacis Glabrae 100g, Herba Scutellariae Barbatae 60g, Herba Violae 100g, Herba Cistanches 19g, Semen Plantaginis 30g, Radix Achyranthis Bidentatae 15g, Fructus Lycii 20g, Cortex Phellodendri (parched) 10g, Radix Glycyrrhizae Preparata 19g, Rhizoma Saururi (Herba Saururi) 100g, Herba Lysimachiae 100g, Rhizoma Sparganii 25g, Radix Cynanchi Paniculati 30g.
Claims (3)
1. treat the Chinese medicine of carcinoma of prostate, it is characterized in that: it is by Herba Lobeliae Chinensis 30-90g, Herba Taraxaci 50-150g, Herba Epimedii 5-25g, stir-baked SQUAMA MANITIS 6-18g, Rhizoma Smilacis Glabrae 50-150g, Herba Scutellariae Barbatae 30-90g, Herba Violae 50-150g, Herba Cistanches 9-29g, Semen Plantaginis 20-40g, Radix Achyranthis Bidentatae 5-25g, Fructus Lycii 10-30g, Cortex Phellodendri (parched) 5-15g, Radix Glycyrrhizae Preparata 9-29g, Rhizoma Saururi (Herba Saururi) 50-150g, Herba Lysimachiae 50-150g, Rhizoma Sparganii 15-3525g, Radix Cynanchi Paniculati 20-40g makes, its preparation method is: the first step is according to the characteristic of every sample medicine, concocting method according to Chinese medicine is concocted respectively, second step is pulverized, and the medicine cooking is ground into powdery.
2. treat according to claim 1 the Chinese medicine of carcinoma of prostate, it is characterized in that: it is to be made by Herba Lobeliae Chinensis 50-70g, Herba Taraxaci 80-120g, Herba Epimedii 10-20g, stir-baked SQUAMA MANITIS 9-15g, Rhizoma Smilacis Glabrae 80-120g, Herba Scutellariae Barbatae 50-70g, Herba Violae 80-120g, Herba Cistanches 14-24g, Semen Plantaginis 20-40g, Radix Achyranthis Bidentatae 10-20g, Fructus Lycii 10-30g, Cortex Phellodendri (parched) 5-15g, Radix Glycyrrhizae Preparata 14-24g, Rhizoma Saururi (Herba Saururi) 80-120g, Herba Lysimachiae 80-120g, Rhizoma Sparganii 20-30g, Radix Cynanchi Paniculati 20-40g.
3. treat according to claim 1 the Chinese medicine of carcinoma of prostate, it is characterized in that: it is to be made by Herba Lobeliae Chinensis 60g, Herba Taraxaci 100g, Herba Epimedii 15g, stir-baked SQUAMA MANITIS 12g, Rhizoma Smilacis Glabrae 100g, Herba Scutellariae Barbatae 60g, Herba Violae 100g, Herba Cistanches 19g, Semen Plantaginis 30g, Radix Achyranthis Bidentatae 15g, Fructus Lycii 20g, Cortex Phellodendri (parched) 10g, Radix Glycyrrhizae Preparata 19g, Rhizoma Saururi (Herba Saururi) 100g, Herba Lysimachiae 100g, Rhizoma Sparganii 25g, Radix Cynanchi Paniculati 30g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410414774.9A CN104173861A (en) | 2014-08-22 | 2014-08-22 | Traditional Chinese medicine for treating prostatic cancer and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410414774.9A CN104173861A (en) | 2014-08-22 | 2014-08-22 | Traditional Chinese medicine for treating prostatic cancer and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104173861A true CN104173861A (en) | 2014-12-03 |
Family
ID=51955387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410414774.9A Pending CN104173861A (en) | 2014-08-22 | 2014-08-22 | Traditional Chinese medicine for treating prostatic cancer and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104173861A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101195022A (en) * | 2007-12-03 | 2008-06-11 | 门连社 | Chinese medicine prescription for curing tumor |
CN101732660A (en) * | 2009-12-25 | 2010-06-16 | 卢速江 | Chinese medicinal preparation for treating prostate disease and preparation method thereof |
-
2014
- 2014-08-22 CN CN201410414774.9A patent/CN104173861A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101195022A (en) * | 2007-12-03 | 2008-06-11 | 门连社 | Chinese medicine prescription for curing tumor |
CN101732660A (en) * | 2009-12-25 | 2010-06-16 | 卢速江 | Chinese medicinal preparation for treating prostate disease and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
孟建华等: "《泌尿系统疾病诊治绝招》", 31 August 2008 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102908603B (en) | Chinese medicament for treating hyperplasia of mammary glands | |
CN104288631A (en) | Medicine composition for treating colon cancer and preparation method thereof | |
CN103611093B (en) | A kind of Chinese medicine composition for the treatment of pulmonary carcinoma | |
CN103784804A (en) | Pharmaceutical composition for treating benign prostatic hyperplasia | |
Jo et al. | Improvements in scrotal thermoregulation in patients with varicoceles treated by using traditional Korean medicine: two case reports | |
CN100398141C (en) | Medicine for treating hyperplasia of mammary glands and preparation method thereof | |
CN103830717B (en) | A kind of Chinese medicine for the treatment of atrophic gastritis and preparation method thereof | |
CN101757521A (en) | Traditional Chinese medicine for treating proliferation of mammary gland | |
CN108853440A (en) | A kind of traditional Chinese medicinal ointment for treating thyroid tumors | |
CN104173861A (en) | Traditional Chinese medicine for treating prostatic cancer and preparation method thereof | |
CN103705864B (en) | A kind of steaming bone hot compress plaster for the treatment of cervical vertebra, lumbar spondylosis | |
CN103495122B (en) | Traditional Chinese medicine for treating urolithiasis | |
CN102657815A (en) | Chinese patent medicine orally-taken pill for treating malignant tumors | |
CN104324091A (en) | Traditional Chinese medicine formula for treating rectal cancer | |
CN104623450A (en) | Traditional Chinese medicine preparation for treating breast cancer | |
CN101036742B (en) | Medicine for treating prostatic disease | |
CN104721532A (en) | Traditional Chinese medicine preparation for treating breast cancer and preparation process | |
CN104888149A (en) | Drug for treating cervical cancer and preparation method for drug | |
CN106266931A (en) | A kind of Chinese medicine composition treating gynecological tumor and preparation method thereof | |
CN104645220A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
CN103028059B (en) | Traditional Chinese medicine composition for treating cholangiocarcinoma | |
CN106237101A (en) | A kind of Chinese medicine formula treating breast carcinoma | |
CN108553585A (en) | It is a kind of to treat lipoma and fibromatous Chinese medicine preparation and preparation method thereof | |
CN105456956A (en) | Traditional Chinese medicine for treating myoma of uterus | |
CN105663906A (en) | Traditional Chinese medicinal composition for treating rectal cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141203 |
|
WD01 | Invention patent application deemed withdrawn after publication |